Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* ICD-9 code for asthma~* one or more outpatient pharmacy claims for fluticasone propionate 44mg or budesonide between January 1, 2000 and June 30, 2008~* ages 4 to 11 years~Exclusion Criteria:~* diagnosis of Cystic Fibrosis~* ≥ 1 Rx claim for any asthma controller in the pre-index period

- Gender: ALL
- Minimum Age: 4 Years
- Maximum Age: 11 Years
- Healthy Volunteers: f

Study Arms:
- Children Ages 4-11 with asthma (Type: None): Children ages 4 to 11 with a diagnosis of asthma receiving a prescription for an asthma therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).